Psychological impact of exercise in women with breast cancer receiving adjuvant therapy: What is the optimal dose needed?

Authors

null

Marion Carayol

Laboratory Epsylon EA 4556 Dynamics of Human Abilities and Health Behaviors, Department of Medicine, Human, Society and Sport Sciences, University of Montpellier and St-Etienne, Montpellier, France

Marion Carayol , Paquito Bernard , Julie Boiche Jr., Francois Riou , Betty Mercier , Florence Cousson-Gelie Sr., Ahmed Jerome Romain , Gregory Ninot Sr.

Organizations

Laboratory Epsylon EA 4556 Dynamics of Human Abilities and Health Behaviors, Department of Medicine, Human, Society and Sport Sciences, University of Montpellier and St-Etienne, Montpellier, France

Research Funding

No funding sources reported
Background: Several meta-analyses have examined the role of exercise interventions in improving psychological outcomes in cancer survivors but most did not focus on adjuvant therapy period and did not investigate the optimal dose of exercise needed. Methods: The present meta-analysis examines the impact of exercise interventions delivered at this particular period on fatigue, anxiety, depression and quality-of-life (QoL) as well as dose-response relationships between volume of prescribed exercise and these psychological outcomes. Randomized controlled trials that proposed an exercise intervention to breast cancer patients undergoing chemotherapy and/or radiotherapy were systematically identified and coded. Standardized mean differences (SMDs) of psychological outcomes were weighted by the inverse of their variances to obtain a pooled estimate using random effects model. Linear and quadratic regressions were carried out to explore dose-response relationships. Results: In total, 17 studies involving 1380 participants and 20 exercise interventions were included. Intervention subjects significantly reduced their fatigue and depression levels showing pooled effect sizes (EF) and their associated 95% confidence interval (95%CI) of -0.28 [95%CI: -0.54; -0.03] and -0.28 [95%CI: -0.46; -0.09] respectively. Levels of anxiety also appeared to be reduced but pooled estimate did not reach significance (p=0.06). Significantly increased QoL was observed: EF=0.34 [95%CI: 0.07; 0.62] favouring intervention. Consistent and significant inverse associations of weekly and total volume of prescribed exercise were observed with fatigue (F test: p=0.04, R²=0.19 and p=0.009, R²=0.26 respectively) and QoL (F test: p=0.01, R²=0.14 and p=0.02, R²=0.29 respectively), implying that SMDs magnitude decreased as exercise dose increased. Conclusions: Exercise intervention enhanced fatigue, depression and QoL in breast cancer patients undergoing adjuvant therapy. Prescription of relatively low doses of exercise (<12 MET.h per week) consisting in approximately 90-120 min of weekly moderate physical exercise seems more efficacious in improving fatigue and QoL than higher doses.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

Palliative Care and Symptom Management

Citation

J Clin Oncol 30, 2012 (suppl; abstr 9074)

DOI

10.1200/jco.2012.30.15_suppl.9074

Abstract #

9074

Poster Bd #

42E

Abstract Disclosures

Similar Abstracts

Abstract

2020 ASCO Virtual Scientific Program

Applying the Collaborative Care Model to treat depression and anxiety in breast cancer (BC) patients.

First Author: Kevin Nathaniel Johns

First Author: Edison Tsui

Abstract

2023 ASCO Annual Meeting

Use of PROMIS to capture patient reported outcomes over time for patients on I-SPY2.

First Author: Saya Jacob

Abstract

2024 ASCO Annual Meeting

A meta-analysis GWAS of taxane-induced peripheral neuropathy in patients with breast cancer.

First Author: Yuanchu James Yang